Dunsire Deborah is a director of Ultragenyx Pharmaceutical Inc.
Person profile
Roles
Ultragenyx Pharmaceutical
Director
Syros Pharmaceuticals
Director
Address
Novato, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ultragenyx Pharmaceutical Inc.
9 Jun 23
4
Syros Pharmaceuticals, Inc.
2 Jun 23
4
Syros Pharmaceuticals, Inc.
19 Sep 22
4
Ultragenyx Pharmaceutical Inc.
28 Jun 22
4
Syros Pharmaceuticals, Inc.
2 Jun 22
4
Syros Pharmaceuticals, Inc.
10 Sep 21
3
Syros Pharmaceuticals, Inc.
10 Sep 21
4
ALEXION PHARMACEUTICALS, INC.
23 Jul 21
4
Ultragenyx Pharmaceutical Inc.
28 Jun 21
4
ALEXION PHARMACEUTICALS, INC.
24 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 23 | RARE Ultragenyx Pharmaceutical | Common Stock | Grant | Acquire A | No | No | 0 | 3,860 | 0.00 | 19,730 |
7 Jun 23 | RARE Ultragenyx Pharmaceutical | Stock Option Common Stock | Grant | Acquire A | No | No | 51.82 | 7,110 | 368.44 k | 7,110 |
1 Jun 23 | SYRS Syros Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 4,000 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.7 | 6,000 | 22.20 k | 6,000 |